INSM : Insmed Incorporated stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-10-31 |
|---|---|---|---|---|
| 2025 | $194.05 | $193.35 | $194.76 | 0.46% |
| 2026 | $165.14 | $150.76 | $190.13 | -14.51% |
| 2027 | $152.12 | $142.27 | $155.85 | -21.25% |
| 2028 | $124.87 | $116.7 | $138.61 | -35.36% |
| 2029 | $195.13 | $131.5 | $248.21 | 1.02% |
| 2030 | $200.58 | $150.99 | $244.44 | 3.84% |
| 2031 | $130.35 | $117.46 | $146.15 | -32.52% |
| 2032 | $99.78 | $87.65 | $113.92 | -48.34% |
| 2033 | $203.1 | $115.46 | $280.09 | 5.14% |
| 2034 | $244.65 | $178.51 | $282.54 | 26.65% |
| 2035 | $139.47 | $128.46 | $166.53 | -27.8% |
The 39 Wall Street analysts offering Insmed Incorporated stock forecast in the last 6 months have average price target of
$146.23 with a high forecast of $240.0 and a low forecast of $90.0.
The average Insmed Incorporated stock forecast represents a -24.3%
decrease from the last price of $193.1699981689453.
For Insmed Incorporated stock forecast for 2025, 2 predictions are offered for each month of 2025 with average Insmed Incorporated stock
forecast of $194.05, a high forecast of $194.76, and a low forecast of $193.35.
The average Insmed Incorporated stock forecast 2025 represents a 0.46%
increase from the last price of $193.1699981689453.
For Insmed Incorporated stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Insmed Incorporated stock
forecast of $165.14, a high forecast of $190.13, and a low forecast of $150.76.
The average Insmed Incorporated stock forecast 2026 represents a -14.51%
decrease from the last price of $193.1699981689453.
For Insmed Incorporated stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Insmed Incorporated stock
forecast of $124.87, a high forecast of $138.61, and a low forecast of $116.7.
The average Insmed Incorporated stock forecast 2028 represents a -35.36%
decrease from the last price of $193.1699981689453.
For Insmed Incorporated stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Insmed Incorporated stock
forecast of $200.58, a high forecast of $244.44, and a low forecast of $150.99.
The average Insmed Incorporated stock forecast 2030 represents a 3.84%
increase from the last price of $193.1699981689453.
For Insmed Incorporated stock forecast 2031, 12 predictions are offered for each month of 2031 with average Insmed Incorporated stock
forecast of $130.35, a high forecast of $146.15, and a low forecast of $117.46.
The average Insmed Incorporated stock forecast 2031 represents a -32.52%
decrease from the last price of $193.1699981689453.
For Insmed Incorporated stock forecast for 2035 (10 year), 10 predictions are offered for each month of 2035 with average Insmed Incorporated stock
forecast of $139.47, a high forecast of $166.53, and a low forecast of $128.46.
The average Insmed Incorporated stock forecast 2035 represents a -27.8%
decrease from the last price of $193.1699981689453.
Please, see more forecasts below.
INSM : Insmed Incorporated stock forecast by Wall Street Analysts
The average Insmed Incorporated stock forecast from last 6 month is $146.23, and this show a 21.62% increase in average from the prior price target of the each prediction. Also, this average forecast of $146.23 represents a 50.67% increase from the past average forecast of $97.05, 6 months ago from 19 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-31 | RBC Capital | $139.0000 | $215.0000 | Outperform |
| 2025-10-31 | Goldman Sachs | $196.00 | $225.0000 | Buy |
| 2025-10-31 | Wells Fargo | $171.00 | $217.0000 | Overweight |
| 2025-10-31 | UBS | $194.00 | $223.0000 | Buy |
| 2025-10-27 | B of A Securities | $142.0000 | $187.0000 | Buy |
| 2025-10-14 | UBS | $140.0000 | $194.0000 | Buy |
| 2025-10-03 | Goldman Sachs | $121.0000 | $196.0000 | Buy |
| 2025-10-02 | TD Cowen | $154.0000 | $193.0000 | Buy |
| 2025-09-08 | Guggenheim | $125 | $172.0000 | Buy |
| 2025-09-03 | Wells Fargo | $140.00 | $171.0000 | Overweight |
| 2025-08-21 | Morgan Stanley | $126.0000 | $144.0000 | Equal-Weight |
| 2025-08-20 | William Blair | Outperform | ||
| 2025-08-20 | JP Morgan | $111.00 | $135.0000 | Overweight |
| 2025-08-14 | Stifel | $121.0000 | $145.0000 | Buy |
| 2025-08-14 | Truist Securities | $126.0000 | $139 | Buy |
| 2025-08-13 | Morgan Stanley | $112.0000 | $126.0000 | Equal-Weight |
| 2025-08-13 | Jefferies | $129.0000 | $148 | Buy |
| 2025-08-13 | Mizuho | $130.0000 | $165 | Outperform |
| 2025-08-13 | Goldman Sachs | $114.0000 | $142 | Buy |
| 2025-08-13 | RBC Capital | $120.00 | $138.0000 | Outperform |
| 2025-08-13 | UBS | $133.00 | $140.0000 | Buy |
| 2025-08-13 | HC Wainwright & Co. | $120.00 | $240.0000 | Buy |
| 2025-08-12 | Wells Fargo | $130.00 | $140.0000 | Overweight |
| 2025-08-08 | UBS | $124.0000 | $133.0000 | Buy |
| 2025-08-08 | RBC Capital | $108.0000 | $120.0000 | Outperform |
| 2025-07-22 | Wells Fargo | $119.0000 | $130.0000 | Overweight |
| 2025-07-17 | Morgan Stanley | $102.00 | $108 | Overweight |
| 2025-07-08 | JP Morgan | $90.0000 | $111.0000 | Overweight |
| 2025-06-11 | Mizuho | $96.0000 | $110 | Outperform |
| 2025-06-11 | Stifel | $92.0000 | $110.0000 | Buy |
| 2025-06-11 | HC Wainwright & Co. | $90.00 | $120.0000 | Buy |
| 2025-06-11 | Wells Fargo | $107.00 | $119.0000 | Overweight |
| 2025-06-11 | B of A Securities | $94.0000 | $109 | Buy |
| 2025-06-11 | Morgan Stanley | $90.00 | $102 | Overweight |
| 2025-06-11 | RBC Capital | $99.0000 | $106.0000 | Outperform |
| 2025-06-11 | Goldman Sachs | $100.0000 | $112 | Buy |
| 2025-06-10 | Leerink Partners | $100.0000 | $115.0000 | Outperform |
| 2025-06-10 | Truist Securities | $108.00 | $108.0000 | Buy |
| 2025-05-13 | Jefferies | $105.0000 | Buy | |
| 2025-05-12 | HC Wainwright & Co. | $90.00 | $90 | Buy |
| 2025-05-09 | UBS | $110.00 | $109.0000 | Buy |
| 2025-04-22 | HC Wainwright & Co. | $90.00 | $90 | Buy |
| 2025-03-20 | B of A Securities | $92.0000 | $96 | Buy |
| 2025-03-19 | RBC Capital | $100.00 | $100 | Outperform |
| 2025-03-06 | UBS | $105.0000 | $110.0000 | Buy |
| 2025-02-25 | Guggenheim | $101.0000 | $101 | Buy |
| 2025-02-25 | RBC Capital | $100 | Outperform | |
| 2025-02-24 | HC Wainwright & Co. | $90.00 | $90 | Buy |
| 2025-02-21 | Truist Securities | $105.00 | $108 | Buy |
| 2025-02-21 | HC Wainwright & Co. | $90.00 | $90 | Buy |
| 2025-02-21 | Stifel | $97.00 | $96 | Buy |
| 2025-02-20 | Cantor Fitzgerald | Overweight | ||
| 2025-02-19 | Cantor Fitzgerald | Overweight | ||
| 2025-02-19 | Wells Fargo | $85.0000 | $107.0000 | Overweight |
| 2025-02-18 | Mizuho | $88.0000 | $96.0000 | Outperform |
| 2025-02-11 | Stifel | $88.0000 | $97 | Buy |
| 2025-02-07 | Guggenheim | $95.0000 | $101.0000 | Buy |
| 2025-02-07 | JP Morgan | $83.00 | $92.0000 | Overweight |
| 2025-02-06 | Morgan Stanley | $85.0000 | $90 | Overweight |
| 2024-11-22 | JP Morgan | $74.00 | $83.0000 | Overweight |
| 2024-11-14 | Mizuho | $92.0000 | $88.0000 | Outperform |
Insmed Incorporated stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-11-03 | $214.14 | 10.86% |
| 2025-11-04 | $217.19 | 1.43% |
| 2025-11-05 | $210.82 | -2.94% |
| 2025-11-06 | $197.82 | -6.17% |
| 2025-11-07 | $189.13 | -4.39% |
INSM : Long term Insmed Incorporated stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Nov. is $194.76 , for 2026 Oct. is $150.76 , for 2029 Oct. is $244.99 , for 2030 Oct. is $164.43 , for 2034 Oct. is $207.71 , and for 2035 Oct. is $128.89.
INSM : Insmed Incorporated stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Nov. | $194.76 | 0.82% |
| 2025 Dec. | $193.35 | -0.72% |
INSM : Insmed Incorporated stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $190.13 | -1.67% |
| 2026 Feb. | $186.24 | -2.05% |
| 2026 Mar. | $181.92 | -2.32% |
| 2026 Apr. | $176.10 | -3.20% |
| 2026 May. | $169.10 | -3.98% |
| 2026 Jun. | $162.20 | -4.08% |
| 2026 Jul. | $156.57 | -3.47% |
| 2026 Aug. | $152.80 | -2.41% |
| 2026 Sep. | $150.98 | -1.19% |
| 2026 Oct. | $150.76 | -0.15% |
| 2026 Nov. | $151.74 | 0.65% |
| 2026 Dec. | $153.15 | 0.93% |
INSM : Insmed Incorporated stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $154.41 | 0.82% |
| 2027 Feb. | $155.29 | 0.57% |
| 2027 Mar. | $155.71 | 0.27% |
| 2027 Apr. | $155.85 | 0.09% |
| 2027 May. | $155.54 | -0.20% |
| 2027 Jun. | $154.89 | -0.42% |
| 2027 Jul. | $153.91 | -0.63% |
| 2027 Aug. | $152.59 | -0.86% |
| 2027 Sep. | $150.80 | -1.17% |
| 2027 Oct. | $148.50 | -1.52% |
| 2027 Nov. | $145.64 | -1.93% |
| 2027 Dec. | $142.27 | -2.31% |
INSM : Insmed Incorporated stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $138.61 | -2.57% |
| 2028 Feb. | $134.66 | -2.85% |
| 2028 Mar. | $130.52 | -3.07% |
| 2028 Apr. | $126.58 | -3.01% |
| 2028 May. | $122.73 | -3.05% |
| 2028 Jun. | $120.52 | -1.80% |
| 2028 Jul. | $123.97 | 2.87% |
| 2028 Aug. | $118.89 | -4.10% |
| 2028 Sep. | $116.70 | -1.84% |
| 2028 Oct. | $117.85 | 0.99% |
| 2028 Nov. | $121.36 | 2.98% |
| 2028 Dec. | $126.04 | 3.86% |
INSM : Insmed Incorporated stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $131.50 | 4.33% |
| 2029 Feb. | $137.86 | 4.84% |
| 2029 Mar. | $145.90 | 5.83% |
| 2029 Apr. | $156.83 | 7.49% |
| 2029 May. | $171.26 | 9.20% |
| 2029 Jun. | $188.68 | 10.17% |
| 2029 Jul. | $207.22 | 9.83% |
| 2029 Aug. | $224.14 | 8.17% |
| 2029 Sep. | $237.23 | 5.84% |
| 2029 Oct. | $244.99 | 3.27% |
| 2029 Nov. | $248.21 | 1.31% |
| 2029 Dec. | $247.77 | -0.17% |
INSM : Insmed Incorporated stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $244.44 | -1.35% |
| 2030 Feb. | $239.16 | -2.16% |
| 2030 Mar. | $233.64 | -2.31% |
| 2030 Apr. | $227.35 | -2.69% |
| 2030 May. | $219.50 | -3.45% |
| 2030 Jun. | $210.12 | -4.28% |
| 2030 Jul. | $199.12 | -5.23% |
| 2030 Aug. | $186.81 | -6.18% |
| 2030 Sep. | $174.65 | -6.51% |
| 2030 Oct. | $164.43 | -5.85% |
| 2030 Nov. | $156.77 | -4.66% |
| 2030 Dec. | $150.99 | -3.69% |
INSM : Insmed Incorporated stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $146.15 | -3.20% |
| 2031 Feb. | $141.60 | -3.12% |
| 2031 Mar. | $137.53 | -2.87% |
| 2031 Apr. | $134.33 | -2.33% |
| 2031 May. | $131.98 | -1.75% |
| 2031 Jun. | $130.20 | -1.35% |
| 2031 Jul. | $128.67 | -1.17% |
| 2031 Aug. | $127.13 | -1.19% |
| 2031 Sep. | $125.37 | -1.38% |
| 2031 Oct. | $123.22 | -1.71% |
| 2031 Nov. | $120.59 | -2.14% |
| 2031 Dec. | $117.46 | -2.59% |
INSM : Insmed Incorporated stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $113.92 | -3.01% |
| 2032 Feb. | $110.12 | -3.34% |
| 2032 Mar. | $106.21 | -3.55% |
| 2032 Apr. | $102.34 | -3.65% |
| 2032 May. | $98.63 | -3.63% |
| 2032 Jun. | $95.16 | -3.51% |
| 2032 Jul. | $92.07 | -3.25% |
| 2032 Aug. | $89.48 | -2.81% |
| 2032 Sep. | $87.65 | -2.04% |
| 2032 Oct. | $87.68 | 0.03% |
| 2032 Nov. | $101.86 | 16.18% |
| 2032 Dec. | $112.27 | 10.22% |
INSM : Insmed Incorporated stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $115.46 | 2.84% |
| 2033 Feb. | $120.90 | 4.71% |
| 2033 Mar. | $131.45 | 8.72% |
| 2033 Apr. | $147.65 | 12.33% |
| 2033 May. | $170.44 | 15.44% |
| 2033 Jun. | $197.88 | 16.10% |
| 2033 Jul. | $224.28 | 13.34% |
| 2033 Aug. | $244.76 | 9.13% |
| 2033 Sep. | $259.24 | 5.91% |
| 2033 Oct. | $269.20 | 3.84% |
| 2033 Nov. | $275.83 | 2.46% |
| 2033 Dec. | $280.09 | 1.54% |
INSM : Insmed Incorporated stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $282.30 | 0.79% |
| 2034 Feb. | $282.54 | 0.09% |
| 2034 Mar. | $280.73 | -0.64% |
| 2034 Apr. | $276.43 | -1.53% |
| 2034 May. | $269.50 | -2.51% |
| 2034 Jun. | $259.80 | -3.60% |
| 2034 Jul. | $248.29 | -4.43% |
| 2034 Aug. | $235.37 | -5.21% |
| 2034 Sep. | $221.76 | -5.78% |
| 2034 Oct. | $207.71 | -6.34% |
| 2034 Nov. | $192.81 | -7.17% |
| 2034 Dec. | $178.51 | -7.42% |
INSM : Insmed Incorporated stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $166.53 | -6.71% |
| 2035 Feb. | $156.75 | -5.87% |
| 2035 Mar. | $148.35 | -5.36% |
| 2035 Apr. | $141.11 | -4.88% |
| 2035 May. | $135.40 | -4.05% |
| 2035 Jun. | $131.43 | -2.93% |
| 2035 Jul. | $129.22 | -1.68% |
| 2035 Aug. | $128.46 | -0.59% |
| 2035 Sep. | $128.56 | 0.08% |
| 2035 Oct. | $128.89 | 0.26% |
Financial Data for Insmed Incorporated stock
Frequently Asked Questions about Insmed Incorporated stock forecast
Is Insmed Incorporated a good long term stock?
From Insmed Incorporated stock forecast , Insmed Incorporated (INSM) stock can be a good investment choice. According to AIPickup, the Insmed Incorporated stock price forecast for 2025 Nov. is $194.7553213199134 From Insmed Incorporated stock forecast , Insmed Incorporated (INSM) stock cannot be a good investment choice. According to AIPickup, the Insmed Incorporated stock price forecast for 2026 Oct. is $150.76162005957735 From Insmed Incorporated stock forecast , Insmed Incorporated (INSM) stock can be a good investment choice. According to AIPickup, the Insmed Incorporated stock price forecast for 2029 Oct. is $244.98886237302762 From Insmed Incorporated stock forecast , Insmed Incorporated (INSM) stock cannot be a good investment choice. According to AIPickup, the Insmed Incorporated stock price forecast for 2030 Oct. is $164.42877155776742 From Insmed Incorporated stock forecast , Insmed Incorporated (INSM) stock can be a good investment choice. According to AIPickup, the Insmed Incorporated stock price forecast for 2034 Oct. is $207.70732441007308 From Insmed Incorporated stock forecast , Insmed Incorporated (INSM) stock cannot be a good investment choice. According to AIPickup, the Insmed Incorporated stock price forecast for 2035 Oct. is $128.89048982446786
Is Insmed Incorporated stock overvalued?
Insmed Incorporated (INSM) stock is expected to go DOWN . Therefore, AIPickup would say that Insmed Incorporated (INSM) stock is overvalued.
Will Insmed Incorporated stock price go up?
No. The Insmed Incorporated stock price forecast for 2026 Oct. is $150.76162005957735
Is Insmed Incorporated stock a good buy now?
Since closing price on 2025-10-31 is $193.1699981689453 and forecast for 2026 Oct. is $150.76, Insmed Incorporated stock is not a good 1 year investment.
14 Days Historical Data for Insmed Incorporated stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| INSM stock price for 2025-10-14 | $161.38 | $163.99 | $161.34 | $164.34 |
| INSM stock price for 2025-10-15 | $163.54 | $162.20 | $161.65 | $165.76 |
| INSM stock price for 2025-10-16 | $163.19 | $163.95 | $162.37 | $166.40 |
| INSM stock price for 2025-10-17 | $165.76 | $163.80 | $161.19 | $166.04 |
| INSM stock price for 2025-10-20 | $167.91 | $167.17 | $163.42 | $168.22 |
| INSM stock price for 2025-10-21 | $165.31 | $166.90 | $162.80 | $168.09 |
| INSM stock price for 2025-10-22 | $160.40 | $165.90 | $159.65 | $166.62 |
| INSM stock price for 2025-10-23 | $160.12 | $159.41 | $154.79 | $160.30 |
| INSM stock price for 2025-10-24 | $159.66 | $161.84 | $158.81 | $162.29 |
| INSM stock price for 2025-10-27 | $164.02 | $162.05 | $160.53 | $164.14 |
| INSM stock price for 2025-10-28 | $165.29 | $164.02 | $163.11 | $167.07 |
| INSM stock price for 2025-10-29 | $166.95 | $166.48 | $163.82 | $167.78 |
| INSM stock price for 2025-10-30 | $194.22 | $171.26 | $167.00 | $194.70 |
| INSM stock price for 2025-10-31 | $193.17 | $194.57 | $191.33 | $197.08 |